|
JPS59170313A
(ja)
|
1983-03-14 |
1984-09-26 |
Kurimoto Iron Works Ltd |
スクリ−ンゲ−ト
|
|
JPS6085739U
(ja)
|
1983-11-18 |
1985-06-13 |
クラリオン株式会社 |
テ−プレコ−ダにおけるピンチロ−ラ装置
|
|
JPS6243003U
(https=)
|
1985-09-05 |
1987-03-14 |
|
|
|
JPH0314566A
(ja)
|
1989-06-09 |
1991-01-23 |
Sankyo Co Ltd |
ベンズイミダゾール誘導体
|
|
US5244912A
(en)
|
1991-03-28 |
1993-09-14 |
Eli Lilly And Company |
6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
|
|
FR2710915B1
(fr)
|
1993-10-04 |
1995-11-24 |
Synthelabo |
Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
|
|
GB9410469D0
(en)
|
1994-05-25 |
1994-07-13 |
Erba Farmitalia |
Imidazolylalkyl derivatives of imidazo (5,1-c) (1,4) benzoxazin-1-one and process for their preparation
|
|
FR2731708B1
(fr)
|
1995-03-13 |
1997-04-30 |
Synthelabo |
Derives de piperidine, leur procede de preparation et leur application en therapeutique
|
|
FR2747678B1
(fr)
|
1996-04-22 |
1998-05-22 |
Synthelabo |
Composes derives d'imidazobenzoxazine, leurs procedes de preparation et leurs utilisations en therapeutique
|
|
US6287693B1
(en)
|
1998-02-25 |
2001-09-11 |
John Claude Savoir |
Stable shaped particles of crystalline organic compounds
|
|
WO2001081343A2
(en)
|
2000-04-21 |
2001-11-01 |
Pharmacia & Upjohn Company |
Compounds for treating fibromyalgia and chronic fatigue syndrome
|
|
ATE273695T1
(de)
|
2000-06-28 |
2004-09-15 |
Smithkline Beecham Plc |
Nassvermahlung
|
|
EP1309594B1
(fr)
|
2000-08-08 |
2004-12-15 |
Sanofi-Aventis |
Derives de benzimidazole, leur preparation et leur application en therapeutique
|
|
FR2816619B1
(fr)
|
2000-11-15 |
2003-01-31 |
Sanofi Synthelabo |
Derives de benzimidazole, leur preparation et leur application en therapeutique
|
|
US6919334B2
(en)
|
2002-09-12 |
2005-07-19 |
Wyeth |
Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine
|
|
KR100772297B1
(ko)
|
2002-11-22 |
2007-11-02 |
니뽄 다바코 산교 가부시키가이샤 |
융합 비시클릭 질소-함유 헤테로사이클
|
|
EP1462103A1
(en)
|
2003-03-25 |
2004-09-29 |
Faust Pharmaceuticals |
NO donors, combination products and uses as modulators of neurotransmitter release
|
|
WO2005080334A1
(ja)
|
2004-02-23 |
2005-09-01 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規へテロ環化合物
|
|
WO2005099688A2
(en)
|
2004-04-07 |
2005-10-27 |
Takeda Pharmaceutical Company Limited |
Cyclic compounds
|
|
US7713954B2
(en)
|
2004-09-30 |
2010-05-11 |
Roche Palo Alto Llc |
Compositions and methods for treating cognitive disorders
|
|
DE102005011058A1
(de)
|
2005-03-10 |
2006-09-14 |
Merck Patent Gmbh |
Substituierte Tetrahydro-pyrrolo-chinolinderivate
|
|
WO2006124874A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Inhibitors of b-raf kinase
|
|
EP1887008B1
(en)
|
2005-05-30 |
2021-04-21 |
Mitsubishi Tanabe Pharma Corporation |
Thienotriazolodiazepine compound and a medicinal use thereof
|
|
KR20080035576A
(ko)
|
2005-08-05 |
2008-04-23 |
아스트라제네카 아베 |
트리사이클릭 벤즈이미다졸 및 대사체 글루타메이트 수용체조절제로서 이들의 용도
|
|
US8975259B2
(en)
|
2007-04-27 |
2015-03-10 |
University Of Rochester |
Compositions and methods for inhibiting G protein signaling
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
WO2009020559A2
(en)
|
2007-08-03 |
2009-02-12 |
The J. David Gladstone Institutes |
Agents that inhibit p-tefb interactions and methods of use thereof
|
|
WO2009084693A1
(ja)
|
2007-12-28 |
2009-07-09 |
Mitsubishi Tanabe Pharma Corporation |
抗癌剤
|
|
DE102008052618A1
(de)
|
2008-10-21 |
2010-04-22 |
Henkel Ag & Co. Kgaa |
Tricyclische Aldehyde und C,H-acide Verbindungen
|
|
WO2010111626A2
(en)
|
2009-03-27 |
2010-09-30 |
Takeda Pharmaceutical Company Limited |
Poly (adp-ribose) polymerase (parp) inhibitors
|
|
TW201105681A
(en)
|
2009-06-10 |
2011-02-16 |
Janssen Pharmaceutica Nv |
Benzimidazole derivatives useful as TRPM8 channel modulators
|
|
TW201103941A
(en)
|
2009-06-10 |
2011-02-01 |
Janssen Pharmaceutica Nv |
Benzimidazole derivatives useful as TRPM8 channel modulators
|
|
WO2011024987A1
(ja)
|
2009-08-31 |
2011-03-03 |
塩野義製薬株式会社 |
芳香族縮合へテロ環誘導体およびそれらを含有する医薬組成物
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2011054851A1
(en)
|
2009-11-05 |
2011-05-12 |
Glaxosmithkline Llc |
Novel process
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
ES2563057T3
(es)
|
2009-11-05 |
2016-03-10 |
Glaxosmithkline Llc |
Inhibidor de bromodominio de benzodiazepina
|
|
RS54645B1
(sr)
|
2009-11-05 |
2016-08-31 |
Glaxosmithkline Llc |
Benzodiazepin kao inhibitor bromodomena
|
|
CA2812043A1
(en)
|
2010-04-23 |
2011-10-27 |
Kineta, Inc. |
Pyrimidinedione anti-viral compounds
|
|
CN103180318B
(zh)
|
2010-05-14 |
2017-05-10 |
达那-法伯癌症研究所 |
雄性避孕组合物以及使用方法
|
|
MX354217B
(es)
|
2010-05-14 |
2018-02-19 |
Dana Farber Cancer Inst Inc |
Composiciones y metodos para el tratamiento de leucemia.
|
|
PL2902030T3
(pl)
|
2010-05-14 |
2017-07-31 |
Dana-Farber Cancer Institute, Inc. |
Związki tienotriazolodiazepinowe do leczenia nowotworu
|
|
WO2011143651A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating metabolism
|
|
US9085582B2
(en)
|
2010-06-22 |
2015-07-21 |
Glaxosmithkline Llc |
Benzotriazolodiazepine compounds inhibitors of bromodomains
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
CA2825028A1
(en)
|
2011-02-09 |
2012-08-16 |
F. Hoffman-La Roche Ag |
Heterocyclic compounds as pi3 kinase inhibitors
|
|
EP2677865A4
(en)
|
2011-02-23 |
2015-04-22 |
Icahn School Med Mount Sinai |
BROMODOMAIN INHIBITORS AS MODULATORS OF GENE EXPRESSION
|
|
WO2012126901A1
(en)
|
2011-03-21 |
2012-09-27 |
F. Hoffmann-La Roche Ag |
Benzoxazepin compounds selective for pi3k p110 delta and methods of use
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2012151512A2
(en)
|
2011-05-04 |
2012-11-08 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
EP2721031B1
(en)
|
2011-06-17 |
2016-01-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
EP2723338A2
(en)
|
2011-06-24 |
2014-04-30 |
The Trustees of Stevens Institute of Technology |
Selective inhibitors of histone deacetylase isoform 6 and methods thereof
|
|
JP2013010719A
(ja)
|
2011-06-30 |
2013-01-17 |
Dainippon Sumitomo Pharma Co Ltd |
ベンズイミダゾロンおよびオキシインドール誘導体ならびにそれらの医薬用途
|
|
JP2014524409A
(ja)
|
2011-07-29 |
2014-09-22 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
Ｈｉｖの治療のための組成物および方法
|
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
WO2013033270A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
|
|
CN105017151B
(zh)
|
2011-08-31 |
2019-04-02 |
大塚制药株式会社 |
喹诺酮化合物
|
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
EP2757887B1
(en)
|
2011-09-22 |
2017-04-26 |
VIIV Healthcare UK Limited |
Pyrrolopyridinone compounds and methods for treating hiv
|
|
CN103857391B
(zh)
|
2011-09-30 |
2016-06-08 |
沈阳蓝桑医药生物技术研发有限公司 |
含有瑞利格内酯的药物组合物及其应用
|
|
EP2771340B1
(en)
|
2011-10-25 |
2016-04-13 |
Sanofi |
6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
RU2640115C2
(ru)
|
2011-11-01 |
2017-12-26 |
Ресверлоджикс Корп. |
Фармацевтические композиции замещенных хиназолинонов
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
WO2013148197A1
(en)
|
2012-03-28 |
2013-10-03 |
The J. David Gladstone Institutes |
Compositions and methods for reactivating latent immunodeficiency virus
|
|
US20130281398A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281396A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
EP2838881B1
(en)
|
2012-04-20 |
2018-08-08 |
AbbVie Inc. |
Isoindolone derivatives
|
|
TWI602820B
(zh)
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|
|
EP2864336B1
(en)
|
2012-06-06 |
2016-11-23 |
Constellation Pharmaceuticals, Inc. |
Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
JP6215315B2
(ja)
|
2012-06-12 |
2017-10-18 |
アッヴィ・インコーポレイテッド |
ピリジノンおよびピリダジノン誘導体
|
|
MX2014015986A
(es)
|
2012-06-25 |
2016-02-11 |
Oncoethix Gmbh |
Metodo para tratar linfoma utilizando compuestos de tienotriazolodiazepina.
|
|
US9610332B2
(en)
|
2012-07-18 |
2017-04-04 |
Massachusetts Institute Of Technology |
Compositions and methods for modulating BRD4 bioactivity
|
|
WO2014028547A1
(en)
|
2012-08-16 |
2014-02-20 |
Glaxosmithkline Llc |
Benzodiazepines for treating small cell lung cancer
|
|
WO2014026997A1
(de)
|
2012-08-16 |
2014-02-20 |
Bayer Pharma Aktiengesellschaft |
2,3-benzodiazepine
|
|
CN104781259B
(zh)
|
2012-09-28 |
2018-06-01 |
拜耳制药股份公司 |
抑制bet蛋白的5-芳基三唑并氮杂*
|
|
CN104968334B
(zh)
|
2012-09-28 |
2018-09-14 |
翁科埃斯克斯有限公司 |
包含噻吩并三唑并二氮杂卓化合物的药物制剂
|
|
HRP20192020T1
(hr)
|
2012-11-09 |
2020-02-07 |
Mmv Medicines For Malaria Venture |
Derivati heteroarila i njihova upotreba
|
|
US9422290B2
(en)
|
2012-11-13 |
2016-08-23 |
Boehringer Ingelheim International Gmbh |
Triazolopyridazine
|
|
EP2920183B1
(en)
|
2012-11-14 |
2017-03-08 |
Glaxosmithkline LLC |
Thieno[3,2-c]pyridin-4(5h)-ones as bet inhibitors
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
HK1211033A1
(en)
|
2012-12-20 |
2016-05-13 |
Bayer Pharma Aktiengesellschaft |
Bet-protein-inhibiting dihydroquinoxalinones
|
|
WO2014095774A1
(de)
|
2012-12-20 |
2014-06-26 |
Bayer Pharma Aktiengesellschaft |
Bet-proteininhibitorische dihydropyridopyrazinone
|
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2014128655A1
(en)
|
2013-02-25 |
2014-08-28 |
Aurigene Discovery Technologies Limited |
Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
|
|
CN105189488B
(zh)
|
2013-02-27 |
2018-07-24 |
百时美施贵宝公司 |
用作溴区结构域抑制剂的咔唑化合物
|
|
US9492460B2
(en)
|
2013-02-27 |
2016-11-15 |
Bristol-Myers Squibb Company |
Carbazole compounds useful as bromodomain inhibitors
|
|
CN105164127A
(zh)
|
2013-03-11 |
2015-12-16 |
艾伯维公司 |
溴结构域抑制剂
|
|
BR112015022674A2
(pt)
|
2013-03-11 |
2017-07-18 |
Abbvie Inc |
inibidores de bromodomínio
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
WO2014139324A1
(en)
|
2013-03-12 |
2014-09-18 |
Abbvie Inc. |
Tetracyclic bromodomain inhibitors
|
|
EP2970193B1
(en)
|
2013-03-12 |
2018-07-25 |
AbbVie Inc. |
Pyrrole amide inhibitors
|
|
US9321764B2
(en)
|
2013-03-12 |
2016-04-26 |
Abbvie Inc. |
Dihydro-pyrrolopyridinone inhibitors
|
|
US9714946B2
(en)
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
WO2014140077A1
(en)
|
2013-03-14 |
2014-09-18 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Furopyridines as bromodomain inhibitors
|
|
NZ710765A
(en)
|
2013-03-14 |
2020-05-29 |
Glaxosmithkline Ip No 2 Ltd |
2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
|
|
JP6464139B2
(ja)
|
2013-03-14 |
2019-02-06 |
コンバージーン・リミテッド・ライアビリティ・カンパニーＣｏｎｖｅｒｇｅｎｅ Ｌｌｃ |
ブロモドメイン含有タンパク質の阻害のための方法および組成物
|
|
CA2904364A1
(en)
|
2013-03-15 |
2014-09-25 |
Epigenetix, Inc. |
Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
|
|
MX366703B
(es)
|
2013-03-15 |
2019-07-22 |
Incyte Holdings Corp |
Heterociclos tricíclicos como inhibidores de la proteína bet.
|
|
SG11201506687RA
(en)
|
2013-03-15 |
2015-09-29 |
Plexxikon Inc |
Heterocyclic compounds and uses thereof
|
|
US9102684B2
(en)
|
2013-03-27 |
2015-08-11 |
Boehringer Ingelheim International Gmbh |
Indolinone analogues
|
|
JP6453845B2
(ja)
|
2013-03-27 |
2019-01-16 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｂｒｄ４阻害薬としてのジヒドロキナゾリノン類似体
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
EP2996689A1
(en)
|
2013-04-17 |
2016-03-23 |
Albert-Ludwigs-Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
EA027139B1
(ru)
|
2013-04-26 |
2017-06-30 |
Бейджин, Лтд. |
Замещенные 5-(3,5-диметилизоксазол-4-ил)индолин-2-оны
|
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
|
US8975417B2
(en)
|
2013-05-27 |
2015-03-10 |
Novartis Ag |
Pyrazolopyrrolidine derivatives and their use in the treatment of disease
|
|
MX2015016344A
(es)
|
2013-05-27 |
2016-03-01 |
Novartis Ag |
Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
|
|
US9714249B2
(en)
|
2013-05-28 |
2017-07-25 |
Novartis Ag |
Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
|
|
CA2912986A1
(en)
|
2013-05-28 |
2014-12-04 |
Novartis Ag |
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
|
|
ITMI20130991A1
(it)
|
2013-06-17 |
2014-12-18 |
Industrie De Nora Spa |
Sistema per la misurazione di correnti presenti sugli elettrodi in celle elettrolitiche interconnesse.
|
|
WO2014202578A1
(de)
|
2013-06-17 |
2014-12-24 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenyl-2,3-benzodiazepine
|
|
EP3010918B1
(en)
|
2013-06-21 |
2018-08-15 |
Zenith Epigenetics Ltd. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
CA2915838C
(en)
|
2013-06-21 |
2023-04-18 |
Zenith Epigenetics Corp. |
Bicyclic bromodomain inhibitors
|
|
AR096758A1
(es)
*
|
2013-06-28 |
2016-02-03 |
Abbvie Inc |
Inhibidores cristalinos de bromodominios
|
|
JP2016525503A
(ja)
|
2013-06-28 |
2016-08-25 |
アッヴィ・インコーポレイテッド |
ブロモドメイン阻害剤
|
|
AR096837A1
(es)
|
2013-07-08 |
2016-02-03 |
Incyte Corp |
Heterociclos tricíclicos como inhibidores de proteínas bet
|
|
US10479777B2
(en)
|
2013-07-16 |
2019-11-19 |
Basf Se |
Herbicidal azines
|
|
AU2014292888B2
(en)
|
2013-07-25 |
2018-03-22 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
KR101672096B1
(ko)
|
2013-09-30 |
2016-11-02 |
주식회사 엘지화학 |
헤테로환 화합물 및 이를 포함하는 유기 발광 소자
|
|
EP3290407B1
(en)
|
2013-10-18 |
2020-01-01 |
Celgene Quanticel Research, Inc |
Bromodomain inhibitors
|
|
WO2015081189A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
WO2015081246A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
US9399640B2
(en)
|
2013-11-26 |
2016-07-26 |
Incyte Corporation |
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
|
|
JP2016539970A
(ja)
|
2013-12-09 |
2016-12-22 |
アッヴィ・インコーポレイテッド |
ブロモドメイン阻害薬として有用なジヒドロピリジノンおよびジヒドロピリダジノン誘導体
|
|
WO2015095492A1
(en)
|
2013-12-19 |
2015-06-25 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
US9822107B2
(en)
|
2013-12-20 |
2017-11-21 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
MY190835A
(en)
|
2014-01-09 |
2022-05-12 |
Orion Corp |
Bicyclic heterrocyclic derivatives as bromodomain inhibitors
|
|
US9580430B2
(en)
|
2014-02-28 |
2017-02-28 |
The Regents Of The University Of Michigan |
9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors
|
|
MX373274B
(es)
|
2014-04-23 |
2020-04-16 |
Takeda Pharmaceuticals Co |
Derivados de isoindolin-1-ona con actividad de modulador alostérico positivo del receptor colinérgico muscarínico m1 para el tratamiento de la enfermedad de alzheimer.
|
|
CR20160545A
(es)
|
2014-04-23 |
2017-03-31 |
Basf Se |
Compuestos de diaminotriazina como herbicidas
|
|
EA034972B1
(ru)
|
2014-04-23 |
2020-04-13 |
Инсайт Корпорейшн |
1h-пирроло[2,3-c]пиридин-7(6h)-оны в качестве ингибиторов белков bet
|
|
JP2017514907A
(ja)
|
2014-05-02 |
2017-06-08 |
オンコエシックス ゲーエムベーハー |
チエノトリアゾロジアゼピン化合物を用いる耐性非ホジキンリンパ腫、髄芽腫及び／又はａｌｋ＋非小細胞肺癌の治療方法
|
|
CN107073014A
(zh)
|
2014-05-02 |
2017-08-18 |
翁科埃斯克斯有限公司 |
利用噻吩并三唑并二氮杂*化合物治疗急性髓细胞白血病和/或急性淋巴细胞性白血病的方法
|
|
WO2015169953A1
(en)
|
2014-05-08 |
2015-11-12 |
Oncoethix Gmbh |
Method of treating glioma using thienotriazolodiazepine compounds
|
|
CA2947970A1
(en)
|
2014-05-08 |
2015-11-12 |
Oncoethix Gmbh |
Method of treating triple-negative breast cancer using thienotriazolodiazepine compounds
|
|
EP3148543B1
(en)
|
2014-05-30 |
2020-04-08 |
Icahn School of Medicine at Mount Sinai |
Small molecule transcription modulators of bromodomains
|
|
CA2952830C
(en)
|
2014-06-20 |
2022-11-01 |
Constellation Pharmaceuticals, Inc. |
Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
|
|
GB2528783B
(en)
|
2014-07-11 |
2019-12-18 |
Jaan Peter Aked Hurditch |
A detachable leash handle
|
|
US9527864B2
(en)
|
2014-09-15 |
2016-12-27 |
Incyte Corporation |
Tricyclic heterocycles as BET protein inhibitors
|
|
EA034931B1
(ru)
|
2014-10-24 |
2020-04-08 |
Бристол-Майерс Сквибб Компани |
Индолкарбоксамидные соединения
|
|
MA40943A
(fr)
*
|
2014-11-10 |
2017-09-19 |
Constellation Pharmaceuticals Inc |
Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
|
|
US10259809B2
(en)
|
2015-02-03 |
2019-04-16 |
Trillium Therapeutics Inc. |
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins
|
|
WO2016186453A1
(en)
|
2015-05-20 |
2016-11-24 |
Kainos Medicine, Inc. |
Quinoline derivatives as bromodomain inhibitors
|
|
MX2017015256A
(es)
|
2015-05-29 |
2018-02-19 |
Shionogi & Co |
Derivados triciclicos que contienen nitrogeno que tienen actividad inhibidora de la replicacion del virus de inmunodeficiencia adquirida (vih).
|
|
CN105039258B
(zh)
|
2015-07-03 |
2018-04-17 |
北京大学 |
将非神经元细胞重编程为神经元样细胞的方法和组合物
|
|
TW201722966A
(zh)
|
2015-10-29 |
2017-07-01 |
英塞特公司 |
Bet蛋白質抑制劑之非晶固體形式
|
|
CN105254635A
(zh)
|
2015-10-30 |
2016-01-20 |
中国药科大学 |
一类咪唑并吡嗪类化合物及其药物组合物和用途
|
|
US20170127985A1
(en)
|
2015-11-11 |
2017-05-11 |
Medtronic Minimed, Inc. |
Sensor set
|
|
CN108602821B
(zh)
|
2015-12-14 |
2021-06-29 |
恒元生物医药科技(苏州)有限公司 |
1h-咪唑并[4,5-b]吡啶基bet溴结构域抑制剂
|
|
WO2017127930A1
(en)
|
2016-01-28 |
2017-08-03 |
Neomed Institute |
Substituted [1,2,4]triazolo[4,3-a]pyridines, their preparation and their use as pharmaceuticals
|
|
CN108770356A
(zh)
|
2016-02-05 |
2018-11-06 |
正大天晴药业集团股份有限公司 |
溴区结构域蛋白抑制剂的三环类化合物及其制备、药物组合物和用途
|
|
KR102643344B1
(ko)
|
2016-06-20 |
2024-03-07 |
인사이트 코포레이션 |
Bet 저해제의 결정질 고체 형태
|
|
CN108069958A
(zh)
|
2016-11-10 |
2018-05-25 |
凯惠科技发展(上海)有限公司 |
一种含氮杂环类化合物、其制备方法、药物组合物及应用
|